11.8%, 15.0%, and 7.5%, respectively. Among the 13 villages in this community, the prevalence of hepatitis B surface antigen(+) ranged from 6.8% to 17.3%, anti-HCV(+) ranged from 7.2% to 37.6%, and an elevated ALT level ranged from 5.8% to 16.5%. A strong positive correlation was found between the prevalence of an elevated ALT level and anti-HCV(+) (r=0.91, Spearman rank correlation; PϽ.001). However, nearly 0 correlation (r =−0.05, P =.87) was obtained between the prevalence of an elevated serum ALT level and hepatitis B surface antigen(+).
Conclusion:
The prevalence of an elevated serum ALT level in a community is a strong indicator of its prevalence of anti-HCV(+), even in areas where there is a similar prevalence of hepatitis B virus infection. This result is useful for economically identifying hyperendemic communities with HCV infection. Med. 2001; 161:392-394 H EPATITIS C VIRUS (HCV) infection is an important public health problem. 1, 2 This communicable disease is difficult to treat and frequently causes advanced liver diseases and related extrahepatic disorders [1] [2] [3] and, thus, its effect on a community with high prevalence is potentially devastating. An effective way of minimizing the effect is to prevent the disease's further spread. Identifying the communities at high risk of HCV infection and the associated risk factors is an important first step.
Arch Intern
Antibody to HCV (anti-HCV) test is the accepted method for the diagnosis of HCV infection. It is routinely used in the screening for HCV infection among blood donors. However, the anti-HCV test has not been widely used in routine health examination and community screening for 2 reasons: its high cost and the difficulty with performing the test in many communities where there is a lack of both necessary technicians and instruments. Cost and feasibility are primary considerations in such health surveillance and surveys. To identify the communities at high risk of HCV infection, there is a need for a much simpler, cost-effective tool.
The serum alanine aminotransferase (ALT) level test had been shown to be a viable and cost-effective screening test for HCV infection that could reduce the incidence of posttransfusion infection. 4, 5 However, with the invention of anti-HCV test, the serum ALT level test has been gradually phased out in blood do- nor screening because of its lower sensitivity, which can subject blood recipients to the unnecessary risk of HCV infection. 6 Its effectiveness in large-scale screening of HCV infection also has been questioned because of its unsatisfactory sensitivity. 7, 8 Although the serum level test may not be ideal for the individual diagnosis of HCV infection, we will show that using the prevalence of an elevated serum ALT level (Ն40 U/L) for identifying communities with high prevalence of HCV infection is valuable.
RESULTS
The prevalence of HBsAg(+) was 11.8% (n = 719), anti-HCV(+) was 15.0% (n = 917), and elevated serum ALT level was 7.5% (n = 459) for the township. The villagespecific prevalence of HBsAg(+) ranged from 6.8% to 17.3%, anti-HCV(+) ranged from 7.2% to 37.6%, and elevated serum ALT level ranged from 5.8% to 16.5%. The Figure shows the relation between the prevalence of an elevated serum ALT level and anti-HCV(+) among the 13 villages, and the relation between the prevalence of an elevated serum ALT level and HBsAg(+). Spearman rank correlation was calculated as 0.91 (PϽ.001), and −0.05 (P=.87), respectively.
COMMENT
We found a strongly positive correlation between the prevalence of an elevated serum ALT level and anti-HCV(+) based on a sample of adults aged 35 years or older. This finding suggests that we can use the prevalence of an elevated serum ALT level for identifying the communities with high prevalence of HCV infection in this adult group. Considering that the per unit cost of the anti-HCV test is 5 to 25 times that of the serum ALT level test, the overall cost for conducting such a regional or national survey of HVC infection can be significantly reduced using the serum ALT level test. Moreover, the serum ALT level test is a routinely used liver function test in clinical practice and periodic health examination. Therefore, performing the serum ALT level test in the field is much more feasible than performing the anti-HCV test. Our data have important implications in terms of cost and feasibility for monitoring a communicable disease in communities, particularly in hyperendemic areas.
In contrast to HCV infection, we found no correlation between the prevalence of an elevated serum ALT level and HBsAg(+). Taiwan is a part of the world with high rates of HBV infection, so if HBV does not interfere with the use of the serum ALT level for the detection of HCV infection in Taiwan, it should not be a problem any-
PARTICIPANTS, MATERIALS, AND METHODS
A sample of 6095 residents aged 35 years or older in a small township in southern Taiwan, Republic of China, were examined during a community health survey. These persons were walk-ins to the government-sponsored stations after an intensive health promotion for this survey. This community has 13 villages with a population of almost 31000 people and has been known for its high prevalence of hepatitis B virus (HBV) and HCV infections. 9, 10 Of those living in this township, 8800 were 35 years old or older. Blood samples were obtained from the participants who were analyzed for serum ALT levels. The analysis was performed on a kinetic UV test for clinical chemistry analyzers (Olympus System Reagent, Mills, Ireland). The cutoff value of 40 U/L or higher was set for the diagnosis of an elevated serum ALT level. Hepatitis B virus infection was assessed for hepatitis B surface antigen (HBsAg) by optical density/ cutoff ratios and enzyme immunoassay using Murex HBsAg Version I (London, England), and HCV infection was assessed by the third-generation Murex anti-HCV enzyme immunoassay, which contains the antigen from the HCV core, nonstructural 3 through 5 regions. For simplicity HBsAg(+) denotes HBsAg(+)/anti-HCV(−), and anti-HCV(+) denotes HBsAg(−)/anti-HCV(+). Seronegative cases were HBsAg(−)/anti-HCV(−). The correlation between the prevalence of an elevated serum ALT level and HBsAg(+) or anti-HCV(+) among the 13 villages was determined using the Spearman rank correlation. where. In summary, the prevalence of an elevated serum ALT level is a valuable index for identifying the communities at the high risk of HCV infection. The increased population with an elevated serum ALT level is more likely to be attributed to HCV infection.
